Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study

• Published in: World journal of surgery Vol. 18; no. 1; p. 150
• Main Authors: Fujimura, T, Yonemura, Y, Muraoka, K, Takamura, H, Hirono, Y, Sahara, H, Ninomiya, I, Matsumoto, H, Tsugawa, K, Nishimura, G
• Format: Journal Article
• Language: English
• Published: United States 01.01.1994
• Subjects: Cisplatin - therapeutic use; Female; Humans; Male; Middle Aged; Mitomycin - blood; Mitomycin - therapeutic use; Perfusion - methods; Peritoneal Neoplasms - blood; Peritoneal Neoplasms - prevention & control; Peritoneal Neoplasms - secondary; Stomach Neoplasms - blood; Stomach Neoplasms - pathology; Stomach Neoplasms - surgery; Temperature

We performed continuous hyperthermic peritoneal perfusion (CHPP) or continuous normothermic peritoneal perfusion (CNPP) combined with cisplatin (CDDP) 300 mg/kg and mitomycin C (MMC) 30 mg/kg in an attempt to prevent peritoneal recurrence after surgery for gastric cancer. Twenty-two patients were tr...